Oxidative stress signaling to chromatin in health and disease

Epigenomics

Volumn 8, Issue 6, 2016, Pages 843-862

  Kreuz, Sarah ^a   Fischle, Wolfgang ^a  

^a KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

cancer; diabetes; DNA methylation; histone acetylation; histone methylation; oxidative stress; RNS; ROS

Indexed keywords

ALDEHYDE; COREPRESSOR PROTEIN; COREPRESSOR PROTEIN KAP1; DNA; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE; LYSINE; NITROGEN DERIVATIVE; PEROXYNITRITE; UNCLASSIFIED DRUG;

CANCER GROWTH; CELL DEATH; CELL FUNCTION; CHROMATIN; CHROMATIN STRUCTURE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DNA DAMAGE; DNA METHYLATION; ENZYME STABILITY; GENE EXPRESSION; GENE REPLICATION; GENETIC STABILITY; GENOMIC INSTABILITY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HUMAN; HUMAN GENOME; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PROTEIN PROCESSING;

ANIMALS; CHROMATIN; DIABETES MELLITUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; NEOPLASMS; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84978196149     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi-2016-0002     Document Type: Review

References (202)

1. Chen Z, Zhong C. Oxidative stress in Alzheimer's disease. Neurosci. Bull. 30(2), 271-281 (2014).
2. Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med. 62, 90-101 (2013)
3. Poon HF, Hensley K, Thongboonkerd V et al. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 39(4), 453-462 (2005)
4. Yan L-J. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J. Diabetes Res. 2014, 137919 (2014)
5. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ. Res. 107(9), 1058-1070 (2010)
6. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25(1), 29-38 (2005)
7. Hernanz R, Briones AM, Salaices M, Alonso MJ. New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension. Clin. Sci. 126(2), 111-121 (2014)
8. Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat. Rev. Rheumatol. 9(11), 674-686 (2013)
9. Block K, Gorin Y. Aiding and abetting roles of NOX oxidases in cellular transformation. Nat. Rev. Cancer 12(9), 627-637 (2012)
10. Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat. Rev. Cancer 14(11), 709-721 (2014)
11. Badeaux AI, Shi Y. Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14(4), 211-224 (2013)
12. Schübeler D. Function and information content of DNA methylation. Nature 517(7534), 321-326 (2015)
13. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 21(3), 381-395 (2011)
14. Sies H, Jones D. Oxidative Stress. In: Encyclopedia of Stress (Second Edition). Fink G (Ed.). Academic Press, New York, USA, 45-48 (2007)
15. Kojer K, Riemer J. Balancing oxidative protein folding: the influences of reducing pathways on disulfide bond formation. Biochim. Biophys. Acta 1844(8), 1383-1390 (2014)
16. López-Mirabal HR, Winther JR. Redox characteristics of the eukaryotic cytosol. Biochim. Biophys. Acta 1783(4), 629-640 (2008)
17. Espinosa-Diez C, Miguel V, Mennerich D et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 6, 183-197 (2015)
18. Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur. J. Med. Chem. 97, 55-74 (2015)
19. Go Y-M, Jones DP. Redox control systems in the nucleus: mechanisms and functions. Antioxid. Redox Signal. 13(4), 489-509 (2010)
20. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 47(4), 333-343 (2009)
21. Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos. Trans. R. Soc. B Biol. Sci. 360(1464), 2335-2345 (2005)
22. Murphy MP. How mitochondria produce reactive oxygen species. Biochem. J. 417(Pt 1), 1-13 (2009)
23. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277(47), 44784-44790 (2002)
24. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4(3), 181-189 (2004)
25. Radi R. Peroxynitrite, a stealthy biological oxidant. J. Biol. Chem. 288(37), 26464-26472 (2013)
26. Petry A, Weitnauer M, Görlach A. Receptor activation of NADPH oxidases. Antioxid. Redox Signal. 13(4), 467-487 (2009)
27. Matsushima S, Kuroda J, Ago T et al. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ. Res. 112(4), 651-663 (2013)
28. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr. Biol. 24(10), R453-R462 (2014)
29. Reczek CR, Chandel NS. ROS-dependent signal transduction. Curr. Opin. Cell Biol. 33, 8-13 (2015)
30. Meng T-C, Fukada T, Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9(2), 387-399 (2002)
31. Lee S-R, Yang K-S, Kwon J, Lee C, Jeong W, Rhee SG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277(23), 20336-20342 (2002)
32. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120(5), 649-661 (2005)
33. Nadeau PJ, Charette SJ, Toledano MB, Landry J. Disulfide bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H2O2-induced c-Jun NH2-terminal kinase activation and apoptosis. Mol. Biol. Cell 18(10), 3903-3913 (2007)
34. Marinho HS, Real C, Cyrne L, Soares H, Antunes F. Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol. 2, 535-562 (2014)
35. Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med. 37(6), 768-784 (2004)
36. Provost C, Choufani F, Avedanian L, Bkaily G, Gobeil F, Jacques D. Nitric oxide and reactive oxygen species in the nucleus revisited. Can. J. Physiol. Pharmacol. 88(3), 296-304 (2010)
37. Saluja R, Jyoti A, Chatterjee M et al. Molecular and biochemical characterization of nitric oxide synthase isoforms and their intracellular distribution in human peripheral blood mononuclear cells. Biochim. Biophys. Acta 1813(10), 1700-1707 (2011)
38. Stuehr DJ, Santolini J, Wang Z-Q, Wei C-C, Adak S. Update on mechanism and catalytic regulation in the NO synthases. J. Biol. Chem. 279(35), 36167-36170 (2004)
39. Hill BG, Dranka BP, Bailey SM, Lancaster JR, Darley-Usmar VM. What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. J. Biol. Chem. 285(26), 19699-19704 (2010)
40. Stamati K, Mudera V, Cheema U. Evolution of oxygen utilization in multicellular organisms and implications for cell signalling in tissue engineering. J. Tissue Eng. 2(1), 2041731411432365 (2011)
41. Crapo JD, Oury T, Rabouille C, Slot JW, Chang LY. Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl Acad. Sci. USA 89(21), 10405-10409 (1992)
42. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid. Redox Signal. 9(12), 2277-2293 (2007)
43. Lodhi IJ, Semenkovich CF. Peroxisomes: a nexus for lipid metabolism and cellular signaling. Cell Metab. 19(3), 380-392 (2014)
44. Nordgren M, Fransen M. Peroxisomal metabolism and oxidative stress. Biochimie 98, 56-62 (2014)
45. Bienert GP, Chaumont F. Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. Biochim. Biophys. Acta 1840(5), 1596-1604 (2014)
46. Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 66, 75-87 (2014)
47. Ye Z-W, Zhang J, Townsend DM, Tew KD. Oxidative stress, redox regulation and diseases of cellular differentiation. Biochim. Biophys. Acta 1850(8), 1607-1621 (2015)
48. Wu Y, Antony S, Meitzler JL, Doroshow JH. Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer Lett. 345(2), 164-173 (2014)
49. Hou Z, Falcone DJ, Subbaramaiah K, Dannenberg AJ. Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification. Carcinogenesis 32(5), 695-702 (2011)
50. Berry C, Hamilton CA, Brosnan MJ et al. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101(18), 2206-2212 (2000)
51. Wever RMF, van Dam T, van Rijn HJM, de Groot F, Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem. Biophys. Res. Commun. 237(2), 340-344 (1997)
52. Vásquez-Vivar J, Kalyanaraman B, Martásek P et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl Acad. Sci. USA 95(16), 9220-9225 (1998)
53. Lin MI, Fulton D, Babbitt R et al. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of l-arginine metabolism to efficient nitric oxide production. J. Biol. Chem. 278(45), 44719-44726 (2003)
54. Ou J, Ou Z, Ackerman AW, Oldham KT, Pritchard KA Jr. Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity. Free Radic. Biol. Med. 34(2), 269-276 (2003)
55. Yim MB, Kang JH, Yim HS, Kwak HS, Chock PB, Stadtman ER. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl Acad. Sci. USA 93(12), 5709-5714 (1996)
56. Crow JP, Sampson JB, Zhuang Y, Thompson JA, Beckman JS. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69(5), 1936-1944 (1997)
57. Góth L, Vitai M, Rass P, Sükei E, Páy A. Detection of a novel familial catalase mutation (Hungarian type D) and the possible risk of inherited catalase deficiency for diabetes mellitus. Electrophoresis 26(9), 1646-1649 (2005)
58. Bostwick DG, Alexander EE, Singh R et al. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 89(1), 123-134 (2000)
59. Min JY, Lim S-O, Jung G. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett. 584(11), 2427-2432 (2010)
60. Farina M, Avila DS, da Rocha JBT, Aschner M. Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem. Int. 62(5), 575-594 (2013)
61. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102(4), 488-496 (2008)
62. Rathore R, Zheng Y-M, Niu C-F et al. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic. Biol. Med. 45(9), 1223-1231 (2008)
63. Hwang NR, Yim S-H, Kim YM et al. Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions. Biochem. J. 423(2), 253-264 (2009)
64. Martínez-Revelles S, Avendaño MS, García-Redondo AB et al. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid. Redox Signal. 18(1), 51-65 (2012)
65. Dixon SJ, Lemberg KM, Lamprecht MR et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5), 1060-1072 (2012)
66. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems and apoptosis. Free Radic. Biol. Med. 48(6), 749-762 (2010)
67. Gehrmann W, Elsner M, Lenzen S. Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β-cells. Diabetes Obes. Metab. 12(Suppl. 2), 149-158 (2010)
68. Angelova PR, Horrocks MH, Klenerman D, Gandhi S, Abramov AY, Shchepinov MS. Lipid peroxidation is essential for α-synuclein-induced cell death. J. Neurochem. 133(4), 582-589 (2015)
69. Meira LB, Bugni JM, Green SL et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 118(7), 2516-2525 (2008)
70. Remmen HV, Ikeno Y, Hamilton M et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 16(1), 29-37 (2003)
71. Mahalingaiah PKS, Singh KP. Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells. PLoS ONE 9(1), e87371 (2014)
72. Al-Shobaili HA, Al Robaee AA, Alzolibani AA, Rasheed Z. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis. Markers 33(1), 19-34 (2012)
73. Lunec J, Herbert K, Blount S, Griffiths HR, Emery P. 8-Hydroxydeoxyguanosine: a marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett. 348(2), 131-138 (1994)
74. Görlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87(1), 26-32 (2000)
75. Julienne H, Zoufir A, Audit B, Arneodo A. Human genome replication proceeds through four chromatin states. PLoS Comput. Biol. 9(10), e1003233 (2013)
76. Yan S-J, Lim SJ, Shi S, Dutta P, Li WX. Unphosphorylated STAT and heterochromatin protect genome stability. FASEB J. 25(1), 232-241 (2011)
77. Wang D, Zhou J, Liu X et al. Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instability. Proc. Natl Acad. Sci. USA 110(14), 5516-5521 (2013)
78. Larson K, Yan S-J, Tsurumi A et al. Heterochromatin formation promotes longevity and represses ribosomal RNA synthesis. PLoS Genet. 8(1), e1002473 (2012)
79. Zhu Q, Pao GM, Huynh AM et al. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477(7363), 179-184 (2011)
80. Bernard P, Maure JF, Partridge JF, Genier S, Javerzat JP, Allshire RC. Requirement of heterochromatin for cohesion at centromeres. Science 294(5551), 2539-2542 (2001)
81. Peters AHFM, O'Carroll D, Scherthan H et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107(3), 323-337 (2001)
82. Halicka HD, Zhao H, Podhorecka M, Traganos F, Darzynkiewicz Z. Cytometric detection of chromatin relaxation, an early reporter of DNA damage response. Cell Cycle Georget. Tex. 8(14), 2233-2237 (2009)
83. Frost B, Hemberg M, Lewis J, Feany MB. Tau promotes neurodegeneration through global chromatin relaxation. Nat. Neurosci. 17(3), 357-366 (2014)
84. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. TOR-mediated cell-cycle activation causes neurodegeneration in a drosophila tauopathy model. Curr. Biol. 16(3), 230-241 (2006)
85. Bosch-Presegué L, Raurell-Vila H, Marazuela-Duque A et al. Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection. Mol. Cell 42(2), 210-223 (2011)
86. Dixit K, Khan MA, Sharma YD, Moinuddin, Alam K. Physicochemical studies on peroxynitrite-modified H3 histone. Int. J. Biol. Macromol. 46(1), 20-26 (2010)
87. Khan MA, Dixit K, Moinuddin, Arif Z, Alam K. Studies on peroxynitrite-modified H1 histone: implications in systemic lupus erythematosus. Biochimie 97, 104-113 (2014)
88. Ayala A, Munoz MF, Arguelles S. Lipid Peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal, lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med. Cell. Longev. Oxidative Med. Cell. Longev. 2014, e360438 (2014)
89. Beisswenger PJ, Howell SK, Smith K, Szwergold BS. Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim. Biophys. Acta 1637(1), 98-106 (2003)
90. Niwa T. 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication. J. Chromatogr. B. Biomed. Sci. App. 731(1), 23-36 (1999)
91. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 44(2), 129-146 (2001)
92. Nagai R, Ikeda K, Higashi T et al. Hydroxyl radical mediates N-(carboxymethyl)lysine formation from amadori product. Biochem. Biophys. Res. Commun. 234(1), 167-172 (1997)
93. Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43(5), 676-683 (1994)
94. Baumann M. Role of advanced glycation end products in hypertension and cardiovascular risk: human studies. J. Am. Soc. Hypertens. JASH 6(6), 427-435 (2012)
95. Srikanth V, Maczurek A, Phan T et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol. Aging 32(5), 763-777 (2011)
96. Alzolibani AA, Al Robaee AA, Al-Shobaili HA, Rasheed Z. 4-Hydroxy-2-nonenal modified histone-H2A: a possible antigenic stimulus for systemic lupus erythematosus autoantibodies. Cell. Immunol. 284(1), 154-162 (2013)
97. Ashraf JM, Ahmad S, Rabbani G et al. Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone. IUBMB Life 66(10), 686-693 (2014)
98. Ashraf JM, Rabbani G, Ahmad S et al. Glycation of H1 histone by 3-deoxyglucosone: effects on protein structure and generation of different advanced glycation end products. PLoS ONE 10(6), e0130630 (2015)
99. Ashraf JM, Ahmad S, Rabbani G et al. 3-Deoxyglucosone: a potential glycating agent accountable for structural alteration in H3 histone protein through generation of different AGEs. PLoS ONE 10(2), e0116804 (2015)
100. Mir AR, Uddin, M Alam K, Ali A. Methylglyoxal mediated conformational changes in histone H2A-generation of carboxyethylated advanced glycation end products. Int. J. Biol. Macromol. 69, 260-266 (2014)
101. Rahmanpour R, Bathaie SZ. Histone H1 structural changes and its interaction with DNA in the presence of high glucose concentration in vivo and in vitro. J. Biomol. Struct. Dyn. 28(4), 575-586 (2011)
102. Galligan JJ, Rose KL, Beavers WN et al. Stable histone adduction by 4-oxo-2-nonenal: a potential link between oxidative stress and epigenetics. J. Am. Chem. Soc. 136(34), 11864-11866 (2014)
103. Chen D, Fang L, Li H, Tang M, Jin C. Cigarette smoke component acrolein modulates chromatin assembly by inhibiting histone acetylation. J. Biol. Chem. 288(30), 21678-21687 (2013)
104. Cervantes-Laurean D, Roberts MJ, Jacobson EL, Jacobson MK. Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment. Free Radic. Biol. Med. 38(6), 786-795 (2005)
105. Manevich Y, Feinstein SI, Fisher AB. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with φGST. Proc. Natl Acad. Sci. USA 101(11), 3780-3785 (2004)
106. Grek CL, Zhang J, Manevich Y, Townsend DM, Tew KD. Causes and consequences of cysteine s-glutathionylation. J. Biol. Chem. 288(37), 26497-26504 (2013)
107. Luca A de, Moroni N, Serafino A et al. Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance. Biochem. J. 440(2), 175-183 (2011)
108. García-Giménez JL, Olaso G, Hake SB et al. Histone H3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure. Antioxid. Redox Signal. 19(12), 1305-1320 (2013)
109. Balasubramanian S, Hurley LH, Neidle S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat. Rev. Drug Discov. 10(4), 261-275 (2011)
110. Clark DW, Phang T, Edwards MG, Geraci MW, Gillespie MN. Promoter G-quadruplex sequences are targets for base oxidation and strand cleavage during hypoxia-induced transcription. Free Radic. Biol. Med. 53(1), 51-59 (2012)
111. Ba X, Bacsi A, Luo J et al. 8-oxoguanine DNA glycosylase-1 augments proinflammatory gene expression by facilitating the recruitment of site-specific transcription factors. J. Immunol. 192(5), 2384-2394 (2014)
112. Valinluck V, Tsai H-H, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32(14), 4100-4108 (2004)
113. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 25(10), 1010-1022 (2011)
114. Dickson KM, Gustafson CB, Young JI, Züchner S, Wang G. Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate. Biochem. Biophys. Res. Commun. 439(4), 522-527 (2013)
115. Ponnaluri VKC, Maciejewski JP, Mukherji M. A mechanistic overview of TET-mediated 5-methylcytosine oxidation. Biochem. Biophys. Res. Commun. 436(2), 115-120 (2013)
116. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 31(12), 2025-2037 (2010)
117. Volkmar M, Dedeurwaerder S, Cunha DA et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 31(6), 1405-1426 (2012)
118. Cheishvili D, Stefanska B, Yi C et al. A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness. Oncotarget 6(32), 33253-33268 (2015)
119. Leodolter A, Alonso S, González B et al. Somatic DNA hypomethylation in H. pylori-associated high-risk gastritis and gastric cancer: enhanced somatic hypomethylation associates with advanced stage cancer. Clin. Transl. Gastroenterol. 6, e85 (2015)
120. Gravina GL, Ranieri G, Muzi P et al. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells. Oncol. Rep. 29(3), 1189-1195 (2013)
121. Avila MA, Corrales FJ, Ruiz F et al. Specific interaction of methionine adenosyltransferase with free radicals. BioFactors 8(1), 27-32 (1998)
122. Pajares MA, Durán C, Corrales F, Pliego MM, Mato JM. Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. J. Biol. Chem. 267(25), 17598-17605 (1992)
123. Jarrett JT, Hoover DM, Ludwig ML, Matthews RG. The mechanism of adenosylmethionine-dependent activation of methionine synthase: a rapid kinetic analysis of Intermediates in reductive methylation of Cob(II)alamin enzyme. Biochemistry (Mosc.). 37(36), 12649-12658 (1998)
124. Lu SC. Regulation of glutathione synthesis. Mol. Aspects Med. 30(1), 42-59 (2009)
125. Cyr AR, Domann FE. The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid. Redox Signal. 15(2), 551-589 (2011)
126. Mosharov E, Cranford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry (Mosc.). 39(42), 13005-13011 (2000)
127. Kloypan C, Srisa-Art M, Mutirangura A, Boonla C. LINE-1 hypomethylation induced by reactive oxygen species is mediated via depletion of S-adenosylmethionine. Cell Biochem. Funct. 33(6), 375-384 (2015)
128. Lertratanangkoon K, Wu CJ, Savaraj N, Thomas ML. Alterations of DNA methylation by glutathione depletion. Cancer Lett. 120(2), 149-156 (1997)
129. Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67(3), 946-950 (2007)
130. Niu Y, DesMarais TL, Tong Z, Yao Y, Costa M. Oxidative stress alters global histone modification and DNA methylation. Free Radic. Biol. Med. 82, 22-28 (2015)
131. Delatte B, Jeschke J, Defrance M et al. Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress. Sci. Rep. 5, 12714 (2015)
132. Xin Y-J, Yuan B, Yu B et al. Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress. Sci. Rep. 5, 7645 (2015)
133. Xiao M, Yang H, Xu W et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26(12), 1326-1338 (2012)
134. Frizzell N, Thomas SA, Carson JA, Baynes JW. Mitochondrial stress causes increased succination of proteins in adipocytes in response to glucotoxicity. Biochem. J. 445(2), 247-254 (2012)
135. Tretter L, Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 20(24), 8972-8979 (2000)
136. O'Hagan HM, Wang W, Sen S et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and Polycomb members to promoter CpG islands. Cancer Cell 20(5), 606-619 (2011)
137. Ding N, Bonham EM, Hannon BE, Amick TR, Baylin SB, O'Hagan HM. Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage. J. Mol. Cell Biol. doi:10.1093/jmcb/mjv050 (2015) (Epub ahead of print)
138. Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol. Cell Biol. 13(5), 297-311 (2012)
139. Sullivan LB, Martinez-Garcia E, Nguyen H et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51(2), 236-248 (2013)
140. Hickok JR, Vasudevan D, Antholine WE, Thomas DD. Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases. J. Biol. Chem. 288(22), 16004-16015 (2013)
141. Hitchler MJ, Domann FE. Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome. Free Radic. Biol. Med. 53(11), 2178-2187 (2012)
142. Kera Y, Katoh Y, Ohta M, Matsumoto M, Takano-Yamamoto T, Igarashi K. Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus. J. Biol. Chem. 288(19), 13592-13601 (2013)
143. Ruijter AJM de, Gennip AH van, Caron HN, Kemp S, Kuilenburg ABP van. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370(3), 737-749 (2003)
144. Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1(3), 194-202 (2001)
145. Delcuve GP, Khan DH, Davie JR. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin. Epigenetics 4(1), 5 (2012)
146. Lombardi PM, Cole KE, Dowling DP, Christianson DW. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes. Curr. Opin. Struct. Biol. 21(6), 735-743 (2011)
147. Khan O, La Thangue NB. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol. Cell Biol. 90(1), 85-94 (2012)
148. Tanny JC, Moazed D. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: evidence for acetyl transfer from substrate to an NAD breakdown product. Proc. Natl Acad. Sci. USA 98(2), 415-420 (2001)
149. Tanner KG, Landry J, Sternglanz R, Denu JM. Silent information regulator 2 family of NAD-dependent histone/ protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl Acad. Sci. USA 97(26), 14178-14182 (2000)
150. Moodie FM, Marwick JA, Anderson CS et al. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-κB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J. 18(15), 1897-1899 (2004)
151. Doyle K, Fitzpatrick FA. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J. Biol. Chem. 285(23), 17417-17424 (2010)
152. Kornberg MD, Sen N, Hara MR et al. GAPDH mediates nitrosylation of nuclear proteins. Nat. Cell Biol. 12(11), 1094-1100 (2010)
153. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A. S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455(7211), 411-415 (2008)
154. Colussi C, Mozzetta C, Gurtner A et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc. Natl Acad. Sci. USA 105(49), 19183-19187 (2008)
155. Bhaskara S, Knutson SK, Jiang G et al. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 18(5), 436-447 (2010)
156. Dovey OM, Foster CT, Conte N et al. Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice. Blood 121(8), 1335-1344 (2013)
157. Heideman MR, Wilting RH, Yanover E et al. Dosagedependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function. Blood 121(11), 2038-2050 (2013)
158. Santoro F, Botrugno OA, Zuffo RD et al. A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood 121(17), 3459-3468 (2013)
159. Shimazu T, Hirschey MD, Newman J et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339(6116), 211-214 (2013)
160. Caito S, Rajendrasozhan S, Cook S et al. SIRT1 is a redoxsensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 24(9), 3145-3159 (2010)
161. Shao D, Fry JL, Han J et al. A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress. J. Biol. Chem. 289(11), 7293-7306 (2014)
162. Yao H, Chung S, Hwang J-W et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J. Clin. Invest. 122(6), 2032-2045 (2012)
163. Ota H, Eto M, Kano MR et al. Cilostazol Inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28(9), 1634-1639 (2008)
164. Yang S-R, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am. J. Physiol. Lung Cell Mol. Physiol. 292(2), L567-L576 (2007)
165. Fritz KS, Galligan JJ, Smathers RL et al. 4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chem. Res. Toxicol. 24(5), 651-662 (2011)
166. Iwahara T, Bonasio R, Narendra V, Reinberg D. SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol. Cell Biol. 32(24), 5022-5034 (2012)
167. Hu S, Liu H, Ha Y et al. Posttranslational modification of Sirt6 activity by peroxynitrite. Free Radic. Biol. Med. 79, 176-185 (2015)
168. Sebastián C, Zwaans BMM, Silberman DM et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151(6), 1185-1199 (2012)
169. Liu Y, Hernández-Ochoa EO, Randall WR, Schneider MF. NOX2-dependent ROS is required for HDAC5 nuclear efflux and contributes to HDAC4 nuclear efflux during intense repetitive activity of fast skeletal muscle fibers. Am. J. Physiol. Cell Physiol. 303(3), C334-C347 (2012)
170. Lu J, McKinsey TA, Nicol RL, Olson EN. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl Acad. Sci. USA 97(8), 4070-4075 (2000)
171. Hwang J, Yao H, Caito S, Sundar IK, Rahman I. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic. Biol. Med. 61, 95-110
172. Agudelo M, Gandhi N, Saiyed Z et al. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). Alcohol. Clin. Exp. Res. 35(8), 1550-1556 (2011)
173. Castonguay Z, Auger C, Thomas SC, Chahma M'hamed, Appanna VD. Nuclear lactate dehydrogenase modulates histone modification in human hepatocytes. Biochem. Biophys. Res. Commun. 454(1), 172-177 (2014)
174. Banerjee T, Chakravarti D. A peek into the complex realm of histone phosphorylation. Mol. Cell Biol. 31(24), 4858-4873 (2011)
175. Ye B, Hou N, Xiao L, Xu Y, Xu H, Li F. Dynamic monitoring of oxidative DNA double-strand break and repair in cardiomyocytes. Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol. 25(2), 93-100 (2016)
176. Mah L-J, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 24(4), 679-686 (2010)
177. Katsube T, Mori M, Tsuji H et al. Most hydrogen peroxideinduced histone H2AX phosphorylation is mediated by ATR and is not dependent on DNA double-strand breaks. J. Biochem. 156(2), 85-95 (2014)
178. Marwick JA, Tudor C, Khorasani N, Michaeloudes C, Bhavsar PK, Chung KF. Oxidants induce a corticosteroid-insensitive phosphorylation of histone 3 at serine 10 in monocytes. PLoS ONE 10(4), e0124961 (2015)
179. Jeong M-W, Kang T-H, Kim W, Choi YH, Kim K-T. Mitogenactivated protein kinase phosphatase 2 regulates histone H3 phosphorylation via interaction with vaccinia-related kinase 1. Mol. Biol. Cell 24(3), 373-384 (2013)
180. Rusnak F, Reiter T. Sensing electrons: protein phosphatase redox regulation. Trends Biochem. Sci. 25(11), 527-529 (2000)
181. Iyengar S, Farnham PJ. KAP1 protein: an enigmatic master regulator of the genome. J. Biol. Chem. 286(30), 26267-26276 (2011)
182. Wei N, Shi Y, Truong LN et al. Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage. Mol. Cell 56(2), 323-332 (2014)
183. Higo S, Asano Y, Kato H et al. Isoform-specific intermolecular disulfide bond formation of heterochromatin protein 1 (HP1). J. Biol. Chem. 285(41), 31337-31347 (2010)
184. Whitelaw NC, Chong S, Morgan DK et al. Reduced levels of two modifiers of epigenetic gene silencing, Dnmt3a and Trim28, cause increased phenotypic noise. Genome Biol. 11(11), R111 (2010)
185. Štros M. HMGB proteins: interactions with DNA and chromatin. Biochim. Biophys. Acta BBA 1799(1), 101-113 (2010)
186. Polanská E, PospíŜilová Š, Štros M. Binding of histone H1 to DNA is differentially modulated by redox state of HMGB1. PLoS ONE 9(2), e89070 (2014)
187. Fiume R, Stijf-Bultsma Y, Shah ZH et al. PIP4K and the role of nuclear phosphoinositides in tumour suppression. Biochim. Biophys. Acta 1851(6), 898-910 (2015)
188. Keune W jan, Bultsma Y, Sommer L, Jones D, Divecha N. Phosphoinositide signalling in the nucleus. Adv. Enzyme Regul. 51(1), 91-99 (2011)
189. Jones DR, Bultsma Y, Keune W-J et al. Nuclear PtdIns5P as a transducer of stress signaling: an in vivo role for PIP4Kbeta. Mol. Cell 23(5), 685-695 (2006)
190. Attia SM, Ahmad SF, Harisa GI, Mansour AM, El Sayed ESM, Bakheet SA. Wogonin attenuates etoposide-induced oxidative DNA damage and apoptosis via suppression of oxidative DNA stress and modulation of OGG1 expression. Food Chem. Toxicol. 59, 724-730 (2013)
191. Gozani O, Karuman P, Jones DR et al. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114(1), 99-111 (2003)
192. Pedeux R, Sengupta S, Shen JC et al. ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol. Cell Biol. 25(15), 6639-6648 (2005)
193. Doyon Y, Cayrou C, Ullah M et al. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol. Cell 21(1), 51-64 (2006)
194. Bua DJ, Martin GM, Binda O, Gozani O. Nuclear phosphatidylinositol-5-phosphate regulates ING2 stability at discrete chromatin targets in response to DNA damage. Sci. Rep. 3, 2137 (2013)
195. Stijf-Bultsma Y, Sommer L, Tauber M et al. The basal transcription complex component TAF3 transduces changes in nuclear phosphoinositides into transcriptional output. Mol. Cell 58(3), 453-467 (2015)
196. Bronner C. Control of DNMT1 abundance in epigenetic inheritance by acetylation, ubiquitylation, and the histone code. Sci. Signal. 4(157), pe3 (2011)
197. Gelato KA, Tauber M, Ong MS et al. Accessibility of different histone H3-binding domains of UHRF1 is allosterically regulated by phosphatidylinositol 5-phosphate. Mol. Cell 54(6), 905-919 (2014)
198. Montero D, Walther G, Stehouwer CDA, Houben AJHM, Beckman JA, Vinet A. Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Obes. Rev. 15(2), 107-116 (2014)
199. Rafieian-Kopaie M, Nasri H. On the Occasion of World Cancer Day 2015; the possibility of cancer prevention or treatment with antioxidants: the ongoing cancer prevention researches. Int. J. Prev. Med. 6, 108 (2015)
200. Galasko DR, Peskind E, Clark CM et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 69(7), 836-841 (2012)
201. Harrison FE, Allard J, Bixler R et al. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice. Nutr. Neurosci. 12(5), 203-218 (2009)
202. Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochim. Biophys. Acta 1842(8), 1282-1294 (2014)